$3.690
+0.103 (+2.79%)收盘时
HCTI 资讯
HCTI 事件
Healthcare Triangle Expands Potential Business in Indonesia to $45M
Healthcare Triangle announced an update on its expansion into Indonesia through its wholly owned subsidiary, Quantum Nexis. Based on its engagements to date, Quantum Nexis has identified an estimated opportunity of approximately $45M of potential cumulative business across hospital, government, enterprise wellness and neuroscience programs. As of the date of this release, the company has not entered into definitive agreements for these opportunities, which are at various stages of the sales cycle. Highlights: Opportunity pipeline: Estimated at approximately $20-$45M over the next 24-36 months. The estimate reflects the unweighted aggregate potential contract value of opportunities under active discussion, proposed pilots and prospective partnerships. It is not contracted revenue, backlog or guidance, and some or all of these opportunities may not result in definitive agreements or revenue. Market: Indonesia, with more than 280M people, is Southeast Asia's largest economy. Its healthcare market was valued at approximately $11.6B in 2024 and its e-health market at approximately $3.5B, according to Nexdigm. Three platforms: Ezovion (hospital information management and electronic health records), Ziloy.ai (digital mental health and employee wellness) and the company's neurotechnology devices and solutions (neuroscience and brain mapping), giving the company several entry points with the same customers. Go-to-market: Engagements with government stakeholders, hospital networks, wellness organizations, consulting partners and technology providers. The company is evaluating partnership and joint venture structures with local partners. Current activity: Discussions are in progress on neurotechnology pilot deployments, Ziloy.ai employee wellness programs and Ezovion-based hospital digitization projects.
Healthcare Triangle's Teyame Signs Six Client Engagements, Estimated Annual Revenue of $1.34M
Healthcare Triangle highlighted developments across its AI-enabled customer engagement and healthcare technology operations, including six signed client engagements at its Teyame business. Teyame reports that its six signed engagements are estimated by management to generate approximately $1.34M illion in annual revenue at full run rate, with services scheduled to begin in October and November 2026. Teyame also expects to sign a separate additional engagement targeting approximately $3.31M in incremental annual revenue beginning in January 2027. If that additional engagement is signed and all seven engagements achieve their respective targeted annual run rates, the combined amount would be approximately $4.65M.
Healthcare Triangle Signs MOU with AI World
Healthcare Triangle announced that it has entered into a Memorandum of Understanding with AI World Sdn. Bhd., a Malaysian company specializing in information technology, artificial intelligence and humanoid robotics, to establish a joint venture to bring AI-enabled humanoid nursing robots to hospitals and clinical settings across North America. "Under the MOU, the parties intend to form a new joint venture company that would hold the intellectual property and distribution rights for the robots in North America. HCTI is expected to hold a 70% ownership interest in the joint venture and AI World 30%. HCTI will aim to use its established network of the over 140 hospital relationships it has built over the years to bring these robots to market after obtaining the required approvals, and applicable regulatory clearances," the company stated.
Healthcare Triangle Signs LOI to Acquire Roboticom
Healthcare Triangle announced it has signed a non-binding Letter of Intent with Crestpoint Capital outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom, a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob, ORTIS and ScultoRob product lines and serving aerospace, marine, composites, orthotics and prosthetics, and industrial-tooling customers. HCTI believes that, if consummated, the proposed acquisition could potentially extend the company's technology platform beyond healthcare into industrial automation and advanced manufacturing - sectors the Company believes are experiencing significant growth driven in part by AI adoption - while creating an opportunity to combine HCTI's existing artificial intelligence, cloud and data capabilities with Roboticom's established industrial robotics platform. Roboticom's technology is marketed through its SandRob, ORTIS and ScultoRob product lines and serves applications across aerospace, marine, composites, orthotics and prosthetics, automotive, advanced manufacturing and industrial tooling. Based on unaudited financial information provided by Roboticom's current ownership group, the business generated approximately $14.1M in revenue and $6.9M in gross margin and was EBITDA-positive for fiscal year 2025. Roboticom management's five-year Growth and Operating Plan, prepared solely by Roboticom management, targets the business to reach approximately $153.5M in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30. Under the terms outlined in the LOI, HCTI would acquire 100% of the customer contracts, identified intellectual property, trademarks and business assets for total consideration of up to $30M in cash and equity paid over time.
Healthcare Triangle Signs Separation Agreement with Teyame AI Holdings
Healthcare Triangle announced that it has signed a separation agreement with its subsidiary Teyame AI Holdings setting forth the terms governing the planned separation of Teyame AI Holdings from HCTI. The Separation Agreement addresses, among other matters, the allocation of assets and liabilities between HCTI and Teyame AI Holdings, transition services to be provided between the companies, and other terms customary for a transaction of this type. In connection with the Separation, the Company has planned a direct listing of Teyame AI Holding's common stock on NASDAQ. Teyame AI Holdings holds HCTI's recently acquired AI-powered customer experience businesses, Teyame 360 S.L. and Datono Mediacion S.L., which HCTI acquired pursuant to a definitive share purchase agreement dated January 22, 2026. In connection with the planned separation, HCTI's Board of Directors has approved a stock dividend pursuant to which HCTI will distribute a Minority Interest of the outstanding shares of Teyame AI Holdings common stock to holders of HCTI common stock as of the record date to be prescribed in future filings upon the approval by NASDAQ of the Direct Listing.
相关文章
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。